Acurx Pharmaceuticals Ownership 2024 | Who Owns Acurx Pharmaceuticals Now?
Institutional Ownership
7.78%
Insider Ownership
14.80%
Retail Ownership
77.41%
Institutional Holders
25.00
Acurx Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VANGUARD GROUP INC | 3.18% | - | 491,687 | - | - | 1,106,296 | Jun 30, 2024 |
PROSPECT FINANCIAL SERVICES LLC | 1.80% | 0.48% | 278,100 | 5,250 | 1.92% | 625,725 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.84% | - | 130,015 | 13,663 | 11.74% | 292,574 | Jun 30, 2024 |
LPL FINANCIAL LLC | 0.35% | 0.00% | 53,735 | 13,500 | 33.55% | 120,904 | Jun 30, 2024 |
MORGAN STANLEY | 0.30% | - | 46,401 | 20,000 | 75.75% | 104,402 | Jun 30, 2024 |
STATE STREET CORP | 0.28% | - | 43,466 | - | - | 97,799,000 | Jun 30, 2024 |
BLACKROCK INC. | 0.18% | - | 27,503 | 8,815 | 47.17% | 61,882 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.18% | - | 27,286 | 10,133 | 59.07% | 61,394,000 | Jun 30, 2024 |
NBC SECURITIES, INC. | 0.12% | 0.00% | 19,000 | 5,000 | 35.71% | 42,000 | Jun 30, 2024 |
TD WATERHOUSE CANADA INC. | 0.12% | 0.00% | 18,656 | - | - | 49,275 | Jun 30, 2024 |
ADVISOR GROUP HOLDINGS, INC. | 0.10% | 0.00% | 15,210 | -42,040 | -73.43% | 34,222 | Jun 30, 2024 |
PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | 0.07% | 0.00% | 10,385 | - | - | 23,366 | Jun 30, 2024 |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 0.06% | 0.00% | 10,000 | - | - | 23,000 | Jun 30, 2024 |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.06% | 0.00% | 10,000 | - | - | 22,500 | Jun 30, 2024 |
SEMMAX FINANCIAL ADVISORS INC. | 0.04% | 0.00% | 5,879 | - | - | 11,170 | Jun 30, 2024 |
GROUP ONE TRADING, L.P. | 0.03% | - | 5,222 | -8,259 | -61.26% | 11,750,000 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 4,138 | 1,270 | 44.28% | 9,310 | Jun 30, 2024 |
CORNERSTONE PLANNING GROUP LLC | 0.02% | 0.00% | 3,344 | - | - | 6,488 | Jun 30, 2024 |
SIMPLEX TRADING, LLC | 0.02% | - | 2,918 | -7,811 | -72.80% | 6,000 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 881 | 881 | 100.00% | 1,982 | Jun 30, 2024 |
Acurx Pharmaceuticals's largest institutional shareholder is VANGUARD GROUP INC, holding 3.18% of the company's total share outstanding, currently valued at $1.11M. The top 10 institutional shareholders own together 7.34% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PROSPECT FINANCIAL SERVICES LLC | 1.80% | 0.48% | 278,100 | 5,250 | 1.92% | 625,725 | Jun 30, 2024 |
NBC SECURITIES, INC. | 0.12% | 0.00% | 19,000 | 5,000 | 35.71% | 42,000 | Jun 30, 2024 |
PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | 0.07% | 0.00% | 10,385 | - | - | 23,366 | Jun 30, 2024 |
SEMMAX FINANCIAL ADVISORS INC. | 0.04% | 0.00% | 5,879 | - | - | 11,170 | Jun 30, 2024 |
CORNERSTONE PLANNING GROUP LLC | 0.02% | 0.00% | 3,344 | - | - | 6,488 | Jun 30, 2024 |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.06% | 0.00% | 10,000 | - | - | 22,500 | Jun 30, 2024 |
TD WATERHOUSE CANADA INC. | 0.12% | 0.00% | 18,656 | - | - | 49,275 | Jun 30, 2024 |
GPS WEALTH STRATEGIES GROUP, LLC | 0.00% | 0.00% | 500 | - | - | 1,125 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 4,138 | 1,270 | 44.28% | 9,310 | Jun 30, 2024 |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 0.06% | 0.00% | 10,000 | - | - | 23,000 | Jun 30, 2024 |
ADVISOR GROUP HOLDINGS, INC. | 0.10% | 0.00% | 15,210 | -42,040 | -73.43% | 34,222 | Jun 30, 2024 |
LPL FINANCIAL LLC | 0.35% | 0.00% | 53,735 | 13,500 | 33.55% | 120,904 | Jun 30, 2024 |
GROUP ONE TRADING, L.P. | 0.03% | - | 5,222 | -8,259 | -61.26% | 11,750,000 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.84% | - | 130,015 | 13,663 | 11.74% | 292,574 | Jun 30, 2024 |
VANGUARD GROUP INC | 3.18% | - | 491,687 | - | - | 1,106,296 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.18% | - | 27,286 | 10,133 | 59.07% | 61,394,000 | Jun 30, 2024 |
MORGAN STANLEY | 0.30% | - | 46,401 | 20,000 | 75.75% | 104,402 | Jun 30, 2024 |
STATE STREET CORP | 0.28% | - | 43,466 | - | - | 97,799,000 | Jun 30, 2024 |
SIMPLEX TRADING, LLC | 0.02% | - | 2,918 | -7,811 | -72.80% | 6,000 | Jun 30, 2024 |
BLACKROCK INC. | 0.18% | - | 27,503 | 8,815 | 47.17% | 61,882 | Jun 30, 2024 |
The largest Acurx Pharmaceuticals shareholder by % of total assets is PROSPECT FINANCIAL SERVICES LLC. The company owns 278.10K shares of Acurx Pharmaceuticals (ACXP), representing 0.48% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MORGAN STANLEY | 0.30% | - | 46,401 | 20,000 | 75.75% | 104,402 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.84% | - | 130,015 | 13,663 | 11.74% | 292,574 | Jun 30, 2024 |
LPL FINANCIAL LLC | 0.35% | 0.00% | 53,735 | 13,500 | 33.55% | 120,904 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.18% | - | 27,286 | 10,133 | 59.07% | 61,394,000 | Jun 30, 2024 |
BLACKROCK INC. | 0.18% | - | 27,503 | 8,815 | 47.17% | 61,882 | Jun 30, 2024 |
PROSPECT FINANCIAL SERVICES LLC | 1.80% | 0.48% | 278,100 | 5,250 | 1.92% | 625,725 | Jun 30, 2024 |
NBC SECURITIES, INC. | 0.12% | 0.00% | 19,000 | 5,000 | 35.71% | 42,000 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 4,138 | 1,270 | 44.28% | 9,310 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 881 | 881 | 100.00% | 1,982 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 105 | 105 | 100.00% | 236 | Jun 30, 2024 |
STATE STREET CORP | 0.28% | - | 43,466 | - | - | 97,799,000 | Jun 30, 2024 |
VANGUARD GROUP INC | 3.18% | - | 491,687 | - | - | 1,106,296 | Jun 30, 2024 |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 0.06% | 0.00% | 10,000 | - | - | 23,000 | Jun 30, 2024 |
GPS WEALTH STRATEGIES GROUP, LLC | 0.00% | 0.00% | 500 | - | - | 1,125 | Jun 30, 2024 |
TD WATERHOUSE CANADA INC. | 0.12% | 0.00% | 18,656 | - | - | 49,275 | Jun 30, 2024 |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.06% | 0.00% | 10,000 | - | - | 22,500 | Jun 30, 2024 |
CORNERSTONE PLANNING GROUP LLC | 0.02% | 0.00% | 3,344 | - | - | 6,488 | Jun 30, 2024 |
SEMMAX FINANCIAL ADVISORS INC. | 0.04% | 0.00% | 5,879 | - | - | 11,170 | Jun 30, 2024 |
PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | 0.07% | 0.00% | 10,385 | - | - | 23,366 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -87 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Acurx Pharmaceuticals's largest institutional buyer is MORGAN STANLEY. The company purchased 20.00K stocks of ACXP, valued at $104.40K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ADVISOR GROUP HOLDINGS, INC. | 0.10% | 0.00% | 15,210 | -42,040 | -73.43% | 34,222 | Jun 30, 2024 |
XTX TOPCO LTD | - | - | - | -13,041 | -100.00% | - | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -12,986 | -100.00% | - | Jun 30, 2024 |
GROUP ONE TRADING, L.P. | 0.03% | - | 5,222 | -8,259 | -61.26% | 11,750,000 | Jun 30, 2024 |
SIMPLEX TRADING, LLC | 0.02% | - | 2,918 | -7,811 | -72.80% | 6,000 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -87 | -100.00% | - | Jun 30, 2024 |
PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | 0.07% | 0.00% | 10,385 | - | - | 23,366 | Jun 30, 2024 |
SEMMAX FINANCIAL ADVISORS INC. | 0.04% | 0.00% | 5,879 | - | - | 11,170 | Jun 30, 2024 |
CORNERSTONE PLANNING GROUP LLC | 0.02% | 0.00% | 3,344 | - | - | 6,488 | Jun 30, 2024 |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.06% | 0.00% | 10,000 | - | - | 22,500 | Jun 30, 2024 |
TD WATERHOUSE CANADA INC. | 0.12% | 0.00% | 18,656 | - | - | 49,275 | Jun 30, 2024 |
GPS WEALTH STRATEGIES GROUP, LLC | 0.00% | 0.00% | 500 | - | - | 1,125 | Jun 30, 2024 |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 0.06% | 0.00% | 10,000 | - | - | 23,000 | Jun 30, 2024 |
VANGUARD GROUP INC | 3.18% | - | 491,687 | - | - | 1,106,296 | Jun 30, 2024 |
STATE STREET CORP | 0.28% | - | 43,466 | - | - | 97,799,000 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 105 | 105 | 100.00% | 236 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 881 | 881 | 100.00% | 1,982 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 4,138 | 1,270 | 44.28% | 9,310 | Jun 30, 2024 |
NBC SECURITIES, INC. | 0.12% | 0.00% | 19,000 | 5,000 | 35.71% | 42,000 | Jun 30, 2024 |
PROSPECT FINANCIAL SERVICES LLC | 1.80% | 0.48% | 278,100 | 5,250 | 1.92% | 625,725 | Jun 30, 2024 |
As of Jun 30 2024, Acurx Pharmaceuticals's biggest institutional seller is ADVISOR GROUP HOLDINGS, INC.. The company sold -42.04K shares of ACXP, valued at $34.22K.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | 0.01% | - | 881 | 881 | 100.00% | 1,982 | Jun 30, 2024 |
Acurx Pharmaceuticals's largest new institutional shareholder by number of shares is UBS GROUP AG, purchased 881.00 shares, valued at $1.98K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
XTX TOPCO LTD | - | - | - | -13,041 | -100.00% | - | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -12,986 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -87 | -100.00% | - | Jun 30, 2024 |
Acurx Pharmaceuticals's largest sold out institutional shareholder by shares sold is XTX TOPCO LTD, sold -13.04K shares, valued at -, as of undefined.
Acurx Pharmaceuticals Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
VANGUARD INDEX FUNDS | 0.00% | 491,687 | -60,237 | -10.91% | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 106,517 | -5,716 | -5.09% | Feb 29, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 1,158 | - | - | Jan 31, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 3,065 | - | - | Jan 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 1,250 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 16,234 | -428 | -2.57% | Mar 31, 2024 |
Dimensional ETF Trust | 0.00% | 200 | - | - | Jan 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 299 | - | - | Mar 31, 2024 |
Acurx Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 491.69K shares, compromising 0.00% of its total assets.
Acurx Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 25 | -7.41% |
31 Mar, 24 | 27 | 8.00% |
31 Dec, 23 | 25 | 47.06% |
30 Sep, 23 | 17 | 41.67% |
30 Jun, 23 | 12 | - |
31 Mar, 23 | 12 | -14.29% |
31 Dec, 22 | 14 | 16.67% |
30 Sep, 22 | 12 | 9.09% |
30 Jun, 22 | 11 | 37.50% |
31 Mar, 22 | 8 | - |
31 Dec, 21 | 8 | 14.29% |
30 Sep, 21 | 7 | 133.33% |
30 Jun, 21 | 3 | - |
As of 30 Jun 24, 25 institutions are holding Acurx Pharmaceuticals's shares, representing a decrease of -7.41% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 1,204,495 | -3.54% |
31 Mar, 24 | 1,248,676 | 14.30% |
31 Dec, 23 | 1,092,462 | 24.40% |
30 Sep, 23 | 878,194 | -40.86% |
30 Jun, 23 | 1,484,920 | 175.70% |
31 Mar, 23 | 538,592 | -59.30% |
31 Dec, 22 | 1,323,380 | -14.74% |
30 Sep, 22 | 1,552,171 | 312.74% |
30 Jun, 22 | 376,069 | 8.04% |
31 Mar, 22 | 348,097 | 236.76% |
31 Dec, 21 | 103,366 | 59.82% |
30 Sep, 21 | 64,675 | 154.01% |
30 Jun, 21 | 25,462 | - |
Acurx Pharmaceuticals (ACXP) has 1.20M shares outstanding as of 30 Jun 24, down -3.54% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 7.78% | 8.02% |
31 Mar, 24 | 9.85% | 13.97% |
31 Dec, 23 | 8.40% | 16.18% |
30 Sep, 23 | 7.21% | 4.43% |
30 Jun, 23 | 12.76% | 59.58% |
31 Mar, 23 | 4.63% | 1.93% |
31 Dec, 22 | 15.50% | 8.00% |
30 Sep, 22 | 13.92% | 103.70% |
30 Jun, 22 | 3.66% | 31.67% |
31 Mar, 22 | 3.40% | 231.97% |
31 Dec, 21 | 1.21% | 296.29% |
30 Sep, 21 | 0.64% | 478.82% |
30 Jun, 21 | 0.37% | - |
As of 30 Jun 24, Acurx Pharmaceuticals is held by 7.78% institutional shareholders, representing a 8.02% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 10 | -41.18% |
31 Mar, 24 | 17 | -10.53% |
31 Dec, 23 | 19 | 58.33% |
30 Sep, 23 | 12 | 50.00% |
30 Jun, 23 | 8 | 60.00% |
31 Mar, 23 | 5 | - |
31 Dec, 22 | 5 | -28.57% |
30 Sep, 22 | 7 | 40.00% |
30 Jun, 22 | 5 | - |
31 Mar, 22 | 5 | -16.67% |
31 Dec, 21 | 6 | -14.29% |
30 Sep, 21 | 7 | 133.33% |
30 Jun, 21 | 3 | - |
10 institutional shareholders have increased their position in ACXP stock as of 30 Jun 24 compared to 17 in the previous quarter (a -41.18% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | 4 | 33.33% |
31 Mar, 24 | 3 | 200.00% |
31 Dec, 23 | 1 | -66.67% |
30 Sep, 23 | 3 | 200.00% |
30 Jun, 23 | 1 | -66.67% |
31 Mar, 23 | 3 | -40.00% |
31 Dec, 22 | 5 | 400.00% |
30 Sep, 22 | 1 | -50.00% |
30 Jun, 22 | 2 | 100.00% |
31 Mar, 22 | 1 | - |
31 Dec, 21 | 1 | - |
30 Sep, 21 | - | - |
30 Jun, 21 | - | - |
4 institutional shareholders have reduced their position in ACXP stock as of 30 Jun 24 compared to 3 in the previous quarter (a 33.33% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 25 | -7.41% | 1,204,495 | -3.54% | 7.78% | 8.02% | 10 | -41.18% | 4 | 33.33% |
31 Mar, 24 | 27 | 8.00% | 1,248,676 | 14.30% | 9.85% | 13.97% | 17 | -10.53% | 3 | 200.00% |
31 Dec, 23 | 25 | 47.06% | 1,092,462 | 24.40% | 8.40% | 16.18% | 19 | 58.33% | 1 | -66.67% |
30 Sep, 23 | 17 | 41.67% | 878,194 | -40.86% | 7.21% | 4.43% | 12 | 50.00% | 3 | 200.00% |
30 Jun, 23 | 12 | - | 1,484,920 | 175.70% | 12.76% | 59.58% | 8 | 60.00% | 1 | -66.67% |
31 Mar, 23 | 12 | -14.29% | 538,592 | -59.30% | 4.63% | 1.93% | 5 | - | 3 | -40.00% |
31 Dec, 22 | 14 | 16.67% | 1,323,380 | -14.74% | 15.50% | 8.00% | 5 | -28.57% | 5 | 400.00% |
30 Sep, 22 | 12 | 9.09% | 1,552,171 | 312.74% | 13.92% | 103.70% | 7 | 40.00% | 1 | -50.00% |
30 Jun, 22 | 11 | 37.50% | 376,069 | 8.04% | 3.66% | 31.67% | 5 | - | 2 | 100.00% |
31 Mar, 22 | 8 | - | 348,097 | 236.76% | 3.40% | 231.97% | 5 | -16.67% | 1 | - |
31 Dec, 21 | 8 | 14.29% | 103,366 | 59.82% | 1.21% | 296.29% | 6 | -14.29% | 1 | - |
30 Sep, 21 | 7 | 133.33% | 64,675 | 154.01% | 0.64% | 478.82% | 7 | 133.33% | - | - |
30 Jun, 21 | 3 | - | 25,462 | - | 0.37% | - | 3 | - | - | - |
Acurx Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Acurx Pharmaceuticals's stock was made by Sailer Carl on Jan 22 2024, selling 19,737 shares at $3.55 per share (valued at $70.07K).
Acurx Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | 5 | - | - |
Q1 2024 | 6 | 3 | 200.00% |
Q4 2023 | - | 2 | - |
Q2 2023 | 5 | - | - |
Q1 2023 | 3 | - | - |
Q3 2022 | 5 | - | - |
Q4 2021 | 3 | 1 | 300.00% |
Q3 2021 | 8 | - | - |
Q2 2021 | 4 | 8 | 50.00% |
Q4 2019 | - | 1 | - |
Q3 2019 | - | 3 | - |
Q1 2019 | - | 1 | - |
Q4 2018 | - | 3 | - |
Q1 2018 | - | 5 | - |
5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Acurx Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | - | - | - |
Q1 2024 | - | - | - |
Q4 2023 | - | - | - |
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q3 2022 | 5 | - | - |
Q4 2021 | 3 | - | - |
Q3 2021 | - | - | - |
Q2 2021 | 1 | - | - |
Q4 2019 | - | - | - |
Q3 2019 | - | - | - |
Q1 2019 | - | - | - |
Q4 2018 | - | - | - |
Q1 2018 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Acurx Pharmaceuticals's stocks.
Acurx Pharmaceuticals Peer Ownership
Ticker | Company |
---|---|
ENOB | Renovaro Biosciences Inc. |
PMVP | PMV Pharmaceuticals, Inc. |
MNPR | Monopar Therapeutics Inc. |
MLYS | Mineralys Therapeutics, Inc. |
AVTE | Aerovate Therapeutics, Inc. |
ACRV | Acrivon Therapeutics, Inc. Common Stock |
ANTX | AN2 Therapeutics, Inc. |
RZLT | Rezolute, Inc. |
CADL | Candel Therapeutics, Inc. |
SILO | Silo Pharma, Inc. |
ANEB | Anebulo Pharmaceuticals, Inc. |
ADAG | Adagene Inc. |
LUMO | Lumos Pharma, Inc. |
ACXP Ownership FAQ
Who Owns Acurx Pharmaceuticals?
Acurx Pharmaceuticals is owned by institutional shareholders (7.78%), insiders (14.80%), and public (77.41%). The largest institutional shareholder of Acurx Pharmaceuticals is VANGUARD GROUP INC (3.18% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).
Who are the major institutional shareholders of Acurx Pharmaceuticals?
Acurx Pharmaceuticals's major institutional shareholders are VANGUARD GROUP INC, PROSPECT FINANCIAL SERVICES LLC, GEODE CAPITAL MANAGEMENT, LLC, LPL FINANCIAL LLC, and MORGAN STANLEY. The top five shareholders own together 6.46% of the company's share outstanding.
How many Acurx Pharmaceuticals shareholders are there?
As of Jun 2024, there are 25 institutional shareholders of Acurx Pharmaceuticals.
What percentage of Acurx Pharmaceuticals is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 491.69K shares of Acurx Pharmaceuticals, representing 3.18% of the company's total shares outstanding, valued at $1.11M (as of Jun 2024).
What percentage of Acurx Pharmaceuticals is owned by PROSPECT FINANCIAL SERVICES LLC?
As of Jun 2024, PROSPECT FINANCIAL SERVICES LLC holds 278.1K shares of Acurx Pharmaceuticals (ACXP), compromising 1.80% of the company, valued at $625.72K.
What percentage of Acurx Pharmaceuticals is owned by GEODE CAPITAL MANAGEMENT, LLC?
GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Acurx Pharmaceuticals. The company owns 130.02K of the company's shares outstanding (worth $292.57K).